News (1893918)

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GL
Union Pacific Railroad Looks to Add Five New Hubs DJ
Federated Hermes, Inc. announces second quarter 2024 earnings and conference call dates PR
Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer AQ
Interactive Strength Inc. (Nasdaq: TRNR) Announces Closing of $4 Million Public Offering AQ
Pomerantz Law Firm Announces the Filing of a Class Action Against Bolt Biotherapeutics, Inc. and Certain Officers - BOLT PR
Andrews Federal Credit Union Partners with Blend To Implement an Omnichannel Deposit Account Opening Solution BU
Interactive Strength Inc. (Nasdaq: TRNR) Announces Pricing of $4 Million Public Offering Form 8 K PU
INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer PR
Olin Corporation Second Quarter 2024 Earnings Conference Call Announcement PR
Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH) PR
Zevia Receives Continued Listing Standard Notice from NYSE BU
Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik AQ
Cipher Mining Announces June 2024 Operational Update GL
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism GL
Innocan Pharma Engages Pain Management Expert in Preparation for Upcoming FDA Meeting AQ
Purple Biotech Announces Closing of Exercise of Warrants for $2 Million Gross Proceeds GL
BAE : BISim™ releases powerful upgrades to VBS4 and VBS Blue IG PU
Watts Water Technologies, Inc. Releases its 2023 Sustainability Report BU
U.S. Civil Rights Act's victories at risk, say leaders on 60th anniversary RE
Lockheed Martin : Slovakian F-16 Block 70 Aircraft Arrives at Morris ANGB PU
TELUS invests $6.6 million in the North Shore region AQ
VusionGroup : Chiffre d’affaires T1 2024 (version anglaise) PU
Union Pacific Expands Opportunities for Businesses to Connect to Rail BU
FDA approves a second Alzheimer's drug that can modestly slow disease AQ
Liberty Defense : Delivers Record Number of HEXWAVE’s to Customer Locations PU
Jack in the Box Makes Triumphant Return to Chicago with Eight Planned Openings and Aggressive Expansion Plans BU
Golden Rapture Mining Announces New CFO and New Board Appointment AQ
Mercialys: Disposal of Four Hypermarkets for €117.5 Million BU
KCC: Update on listing of additional bonds AQ
Eli Lilly and Company's Kisunla?? (donanemab-azbt) Approves by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease CI
Tempur Sealy International Issues Statement on U.S. Federal Trade Commission Challenge of Proposed Acquisition of Mattress Firm PR
ECB's Makhlouf sees one more interest rate cut this year, two is 'too far' RE
Italy seizes 84 million euros from GXO Logistics over alleged tax fraud RE
Science Based Targets Initiative CEO to step down RE
Annual General Meeting approves all agenda items with a strong majority EQ
Frankfurt shares close: Dax weakens - recovery attempt fails DP
Pacira BioSciences Shares Tumble as FDA Approves Exparel Generic DJ
Grand City Properties S.A. announces successful new bond issuance in combination with liability management exercise EQ
Grand City Properties S.A. announces successful new bond issuance in combination with liability management exercise EQ
Virbac: now owns 100% of India's Globion CF
REDCARE PHARMACY : Jefferies gives a Buy rating ZD
DOCMORRIS : Jefferies keeps its Buy rating ZD
Stocks lower amid central bank inflation caution AN
MaaT Pharma Announces First DSMB Positive Review of Ongoing Phase 2 Clinical Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT BU
1234NextSee all

Companies (1984)

TARGET CORPORATION 67 425 M $
Logo Target Corporation

Target Corporation specializes in retail distribution. Net sales break down by family of products as follows: - household and beauty products (26.5%) ; - furnishings and decorative items (19.7%) ; - food and beverage (19.6%); - electronic products, sp ...

KKR & CO. INC. 92 742 M $
Logo KKR & Co. Inc.

KKR & Co. Inc. is an investment company, which offers alternative asset management as well as capital markets and insurance solutions. The Company's asset management business offers a range of investment management services to fund investors around the wo ...

INTESA SANPAOLO S.P.A. 69 470 M $
Logo Intesa Sanpaolo S.p.A.

The Intesa Sanpaolo Group is one of the first European groups to have made a strong commitment to ESG. It is also the first in the world, in terms of social impact, to focus on the climate. The group is the leader in Italy (13.6 million clients; >3,300 br ...

SAFRAN 89 614 M $
Logo Safran

Safran is a high technology international group, a leading equipment provider in the Aerospace and Defense markets. The group specializes in the design, manufacturing, and marketing of equipment and systems of high technology mechanical and electronic equ ...

THE TRADE DESK, INC. 47 920 M $
Logo The Trade Desk, Inc.

The Trade Desk, Inc. specializes in the development and operation of an online platform dedicated to the purchase of advertising space. Based on data, the platform allows advertisers to optimize the placement, execution and management of advertising campa ...

ALNYLAM PHARMACEUTICALS, INC. 30 778 M $
Logo Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. is a clinical-stage company. The Company is engaged in developing mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead product candidate, Descartes-08, is an autologous mRNA CAR-T directed agains ...

CHINA MERCHANTS SECURITIES CO., LTD. 15 058 M $
Logo China Merchants Securities Co., Ltd.

CHINA MERCHANTS SECURITIES CO., LTD is a China-based company, principally engaged in security businesses. The Company operates its businesses through brokerage and wealth management business, including stocks, funds, bonds and financial products trading; ...

BIONTECH SE 19 023 M $
Logo BioNTech SE

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell ...

SAREPTA THERAPEUTICS, INC. 14 817 M $
Logo Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modali ...

CNA FINANCIAL CORPORATION 12 362 M $
Logo CNA Financial Corporation

CNA Financial Corporation is an insurance holding company. The Company’s segments include Specialty, Commercial and International, and Life & Group and Corporate & Other. The Specialty segment offers management and professional liability and other cover ...

ANTERO RESOURCES CORPORATION 9 986 M $
Logo Antero Resources Corporation

Antero Resources Corporation is an independent natural gas and natural gas liquids (NGLs) company. The Company is engaged in the acquisition, development and production of unconventional properties located in the Appalachian Basin in West Virginia and Ohi ...

ZOMATO LIMITED 21 109 M $
Logo Zomato Limited

Zomato Limited operates as an Internet portal that helps in connecting the users, restaurant partners and delivery partners. The Company also provides platform to restaurant partners to advertise themselves to the target audience in India and abroad and s ...

HOLOGIC, INC. 17 293 M $
Logo Hologic, Inc.

Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows: - molecular diagnostic ...

IMMUNOGEN, INC. 8 359 M $
Logo ImmunoGen, Inc.

ImmunoGen, Inc. is a commercial-stage biotechnology company. The Company is focused on developing and commercializing of antibody- drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company's technology comprises an antibody t ...

CEREVEL THERAPEUTICS HOLDINGS, INC. 7 534 M $
Logo Cerevel Therapeutics Holdings, Inc.

Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous ...

LEGEND BIOTECH CORPORATION 8 389 M $
Logo Legend Biotech Corporation

Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...

REVOLUTION MEDICINES, INC. 6 403 M $
Logo Revolution Medicines, Inc.

Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refer ...

LOONGSON TECHNOLOGY CORPORATION LIMITED 4 937 M $
Logo Loongson Technology Corporation Limited

Loongson Technology Corp Ltd is a China-based company mainly engaged in the research, development, manufacturing, and servicing of computer processing units (CPU) and related chips. The Company's main products include Loongson series CPU and related chips ...

ROIVANT SCIENCES LTD. 8 000 M $
Logo Roivant Sciences Ltd.

Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company that seeks to improve the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline is focused on inflammation and immun ...

XPENG INC. 7 284 M $
Logo XPeng Inc.

Xpeng Inc is a China-based company engaged in design, development, production and sales of smart electric vehicles (Smart EV). The Company's primary products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P ...

IONIS PHARMACEUTICALS, INC. 6 871 M $
Logo Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development a ...

OLIN CORPORATION 5 555 M $
Logo Olin Corporation

Olin Corporation is a vertically integrated global manufacturer and distributor of chemical products and a manufacturer of ammunition. The Company operates through three segments: Chlor Alkali Products and Vinyls, Epoxy and Winchester. The Chlor Alkali Pr ...

UBIQUITI INC. 8 905 M $
Logo Ubiquiti Inc.

Ubiquiti Inc. is engaged in developing technology platforms for distributed Internet access, unified information technology, and consumer electronics for professional, home and personal use. Its solutions are categorized into three categories: networking ...

PI INDUSTRIES LIMITED 6 937 M $
Logo PI Industries Limited

PI Industries Limited is a holding company. The Company is engaged in the manufacturing and distribution of agro chemicals. The Company operates through two segments: Agro chemicals, and Pharma. The Agro chemicals segment includes Agchem exports (CSM) and ...

BLUE OWL CAPITAL CORPORATION 5 998 M $
Logo Blue Owl Capital Corporation

Blue Owl Capital Corporation is a specialty finance company focused on lending to United States middle-market companies. The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation by targeting investme ...

CREDIT ACCEPTANCE CORPORATION 6 264 M $
Logo Credit Acceptance Corporation

Credit Acceptance Corporation is engaged in offering that enable automobile dealers to sell vehicles to consumers. The Company’s financing programs are offered through a nationwide network of automobile dealers. Its loan portfolio consists of two portfo ...

CYBERARK SOFTWARE LTD. 11 635 M $
Logo CyberArk Software Ltd.

CyberArk Software Ltd is an Israel-based provider of information technology (IT) security solutions that protect organizations from cyber-attacks. The Company's software solutions are focused on protecting privileged accounts, which have become a critical ...

TWILIO INC. 9 714 M $
Logo Twilio Inc.

Twilio Inc. provides a customer engagement platform comprising communications application programming interfaces. It enables developers to embed numerous forms of messaging, voice, and email interactions into their customer-facing applications, and softwa ...

FIVE BELOW, INC. 5 939 M $
Logo Five Below, Inc.

Five Below, Inc. is a specialty value retailer offering merchandise targeted at the tween and teen demographic. Its assortment of products, including select brands and licensed merchandise. It is engaged in offering a group of products, including leisure, ...

CHORD ENERGY CORPORATION 7 074 M $
Logo Chord Energy Corporation

Chord Energy Corporation is an independent exploration and production company, which is engaged in the acquisition, exploration, development and production of crude oil, natural gas liquids (NGL) and natural gas. The Company’s operations are focused on ...

TELEFÓNICA DEUTSCHLAND HOLDING AG 6 921 M $
Logo Telefónica Deutschland Holding AG

Telefonica Deutschland Holding AG is a Germany-based company in the telecommunications sector. The Company offers mobile and fixed-line services, providing voice, data and other services to private and business customers, as well as digital products and s ...

MURPHY OIL CORPORATION 6 266 M $
Logo Murphy Oil Corporation

Murphy Oil Corporation is an independent oil and gas exploration and production company. The Company is engaged in both onshore and offshore operations and properties. The Company’s geographic segments include the United States, Canada, and all other co ...

EXACT SCIENCES CORPORATION 7 830 M $
Logo Exact Sciences Corporation

Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Co ...

VAXCYTE, INC. 8 371 M $
Logo Vaxcyte, Inc.

Vaxcyte Inc. is a clinical-stage vaccine company. It is engaged in developing a spectrum conjugate and protein vaccines to prevent or treat bacterial infectious diseases. Its lead candidate, VAX-24, is a Phase III-ready 24-valent, carrier-sparing pneumoco ...

CONROY GOLD AND NATURAL RESOURCES PLC 4 M $
Logo Conroy Gold and Natural Resources plc

Conroy Gold and Natural Resources PLC is a resource company, which is engaged in exploring and developing gold projects in Ireland and Finland. Its projects include Clay Lake Gold Target, Clontibret Gold Target, Slieve Glah Gold Targets, Glenish Gold Targ ...

ICENI GOLD LIMITED 11 M $
Logo Iceni Gold Limited

Iceni Gold Limited is an Australia-based gold exploration company that is exploring the 14 Mile Well Project in the Laverton Greenstone Belt of Western Australia. The project is situated midway between the gold mining townships of Leonora and Laverton and ...

OMAT ADVANCED MATERIALS (GUANGDONG) CO.,LTD. 448 M $
Logo Omat Advanced Materials (Guangdong) Co.,Ltd.

OMAT Advanced Materials Guangdong Co Ltd is a China-based company principally engaged in the research, development, production and sales of high-performance sputtering targets. The Company's main products include copper target, aluminum target, molybdenum ...

KONFOONG MATERIALS INTERNATIONAL CO., LTD 1 708 M $
Logo Konfoong Materials International Co., Ltd

Konfoong Materials International Co Ltd is a company engaged in research, development, production and sales of sputtering targets. The Company's products include aluminum targets, titanium targets, tantalum targets and tungsten-titanium targets, which are ...

PIERIS PHARMACEUTICALS, INC. 13 M $
Logo Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals, Inc. is a biotechnology company, which discovers and develops Anticalin-based drugs to target validated disease pathways. The Company’s clinical pipeline consists of immuno-oncology (IO), bispecific in partnership with collaborat ...

ACEPODIA, INC. 441 M $
Logo Acepodia, Inc.

Acepodia Inc is engaged in the research and development of new anti-cancer drugs. The Company uses antibody-cell conjugation (ACC) and immune cells. The products include Gamma delta 2T cell platform including ACE1831 (ACE-gdT-CD20) an antibody linked to s ...

HALCONES PRECIOUS METALS CORP. 3 M $
Logo Halcones Precious Metals Corp.

Halcones Precious Metals Corp. is a Canada-based exploration company focused on gold, silver and copper exploration. The Company is engaged in exploring for and developing gold-silver projects in the Maricunga Belt, Chile, the premiere gold mining distric ...

DELTA-FLY PHARMA, INC. 32 M $
Logo Delta-Fly Pharma, Inc.

Delta-Fly Pharma, Inc. is a Japan-based company principally engaged in the research, development, manufacture and sale of pharmaceuticals. The Company's development pipeline includes anticancer drug candidate compound DFP-10917 whose target disease is ref ...

PINEHRST CA 150 253 $
Logo PINEHRST CA

Halcones Precious Metals Corp. is a Canada-based exploration company focused on gold, silver and copper exploration. The Company is engaged in exploring for and developing gold-silver projects in the Maricunga Belt, Chile, the premiere gold mining distric ...

BETAWAVE CORPORATION 5 $
Logo Betawave Corporation

Betawave Corporation provides online marketing solutions for Websites targeting youth and moms. The Company specializes in aggregating and distributing marketing content on a selected network of targeted sites, mostly virtual worlds and gaming, for which ...

EXICURE, INC. 3 M $
Logo Exicure, Inc.

Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company is into exploring strategic alternatives to maximize stockholder value. It is engaging in ...

BOWEN ACQUISITION CORP 97 M $
Logo Bowen Acquisition Corp

Bowen Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. The Co ...

THOR MEDICAL 23 M $
Logo Thor Medical

Thor Medical ASA, formerly Nordic Nanovector ASA, is a Norway-based biopharmaceutical company. The Company is engaged in the development and commercialization of targeted therapeutics for hematological cancers. Its main product is Betalutin, a CD37-target ...

OCEAN BIOMEDICAL, INC. 42 M $
Logo Ocean Biomedical, Inc.

Ocean Biomedical, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The Company helps to accelerates the development and commerciali ...

NOTABLE LABS, LTD. 5 M $
Logo Notable Labs, Ltd.

Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of the ...

DELTAGEN INC. 32 $
Logo Deltagen Inc.

Deltagen, Inc. is a provider of drug discovery tools and services to the biopharmaceutical industry. The Company offers a suite of programs designed to manage the efficiency of drug discovery, including access to biological models, as well as both small-m ...

RENEURON GROUP PLC 2 M $
Logo ReNeuron Group plc

ReNeuron Group plc is a United Kingdom-based clinical-stage stem cell company. The Company is engaged in the development of stem cell therapies targeting areas of unmet or poorly met medical need. It has developed a stem cell-derived, exosome-based, drug ...

EQUILLIUM, INC. 24 M $
Logo Equillium, Inc.

Equillium, Inc. is a clinical-stage biotechnology company. It is engaged in developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. The Company’s pipeline consists of immunomodulatory assets and ...

BICYCLE THERAPEUTICS PLC 1 397 M $
Logo Bicycle Therapeutics plc

Bicycle Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully sy ...

ABL BIO INC. 849 M $
Logo ABL Bio Inc.

ABL Bio Inc. is a company mainly engaged in the development of biopharmaceuticals. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific ...

HYUNGJI INNOVATION & CREATIVE CO.,LTD 12 M $
Logo HYUNGJI INNOVATION & CREATIVE Co.,Ltd

HYUNGJI Innovation and Creative Company Limited, formerly WOOSUNG INNOVATION & CREATIVE Co.,Ltd is a Korea-based company engaged in the manufacture and marketing of men’s apparels. The Company has four principal brands: YEZAC, which is a luxury styling ...

AURA RENEWABLE ACQUISITIONS PLC 729 830 $
Logo Aura Renewable Acquisitions plc

Aura Renewable Acquisitions plc is a United Kingdom-based holding company. The principal activity of the Company is focused on targeting various businesses operating in the global renewable energy sector supply chain. The purpose of the Company is to seek ...

COMPASS THERAPEUTICS, INC. 130 M $
Logo Compass Therapeutics, Inc.

Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company is developing proprietary antibody-based therapeutics to treat multiple human diseases. Its pipeline of novel product candidates is designed to target ...

PERSEUS PROTEOMICS INC. 44 M $
Logo Perseus Proteomics Inc.

Perseus Proteomics Inc is a Japan-based company principally engaged in the research, development, manufacture and sale of pharmaceuticals. The Company is involved in the research and development of therapeutic drugs for cancer and other diseases and relat ...

SAGE THERAPEUTICS, INC. 664 M $
Logo Sage Therapeutics, Inc.

Sage Therapeutics, Inc. is a biopharmaceutical company. The Company has developed the two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. The Company is targeting diseas ...

APOGEE THERAPEUTICS, INC. 2 255 M $
Logo Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and ...

IKENA ONCOLOGY, INC. 80 M $
Logo Ikena Oncology, Inc.

Ikena Oncology, Inc. is a targeted oncology company. The Company is focused on developing differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. The ...

BIOMX INC. 24 M $
Logo BiomX Inc.

BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, ...

PEGASUS DIGITAL MOBILITY ACQUISITION CORP. 61 M $
Logo Pegasus Digital Mobility Acquisition Corp.

Pegasus Digital Mobility Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesse ...

HAWKEYE SYSTEMS, INC. 4 M $
Logo Hawkeye Systems, Inc.

Hawkeye Systems, Inc. seeks to acquire, merge or consolidate with another company (a target business). The Company is pursuing opportunities to invest in, acquire, merge or consolidate with a target business participating in diversified industries, such a ...

CROWN BAUS CAPITAL CORP. 16 105 $
Logo Crown Baus Capital Corp.

Crown Baus Capital Corp. is focused on becoming a global acquisitions-based company targeting high-tech industries and financial services. The Company uses several consultants to assist in locating potential target companies and procure the financial reso ...

CIDARA THERAPEUTICS, INC. 55 M $
Logo Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc. is a biotechnology company. The Company is developing targeted immunotherapies designed for patients facing serious diseases. The Company’s portfolio comprises various treatment and prevention paradigms, including drug-Fc conju ...

REYNA GOLD CORP. 1 M $
Logo Reyna Gold Corp.

Reyna Gold Corp. is a Canada-based company focused on gold exploration in Northwestern Mexico. The Company’s principal business activity is the acquisition and exploration of mineral properties. Its projects include La Gloria, El Durazno, La Centella, a ...

CHEMOMAB THERAPEUTICS LTD. 14 M $
Logo Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd, formerly known as Anchiano Therapeutics Ltd, is a Israel-based biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeu ...

MERO PART 118 M $
Logo MERO PART

Mercato Partners Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more busi ...

ATLED CORP. 77 M $
Logo ATLED CORP.

ATLED CORP. is a Japan-based company mainly engaged in the development and sale of workflow products. The workflow products are the digitization of the business flow from deliberation, application, approval for various businesses. The main products are pa ...

ARIZ ACQU 13 M $
Logo ARIZ ACQU

Arisz Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Compa ...

VALUENCE MERGER CORP. I 84 M $
Logo Valuence Merger Corp. I

Valuence Merger Corp. I is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It has not select ...

METAL BANK LIMITED 6 M $
Logo Metal Bank Limited

Metal Bank Limited is a mineral exploration company, which holds a portfolio of copper, cobalt and gold exploration projects. It holds a 75% interest in the advanced Livingstone gold project located 140 kilometers (km) northwest of Meekatharra in Western ...

ERASCA, INC. 665 M $
Logo Erasca, Inc.

Erasca, Inc. is a clinical-stage precision oncology company. The Company is focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The Company has assembled a wholly owned or controlled RAS/MAP ...

C4 THERAPEUTICS, INC. 334 M $
Logo C4 Therapeutics, Inc.

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on advancing targeted protein degradation science to create a new generation of small-molecule medicines that transform patients’ lives. By leveraging its proprietary Tar ...

LEAP THERAPEUTICS, INC. 72 M $
Logo Leap Therapeutics, Inc.

Leap Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing targeted and immuno-oncology therapeutics. Its advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-related protein 1 (D ...

ARCH BIOPARTNERS INC. 79 M $
Logo Arch Biopartners Inc.

Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targetin ...

ALTENERGY ACQUISITION CORP. 74 M $
Logo AltEnergy Acquisition Corp.

AltEnergy Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The C ...

CANNA-GLOBAL ACQUISITION CORP 81 M $
Logo Canna-Global Acquisition Corp

Canna-Global Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It ...

SOCL CAP 182 M $
Logo SOCL CAP

Social Capital Suvretta Holdings Corp. I is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. ...

EXACT THERAPEUTICS 22 M $
Logo EXACT Therapeutics

Exact Therapeutics AS is a Norway-based clinical-stage biopharmaceutical company, which develops ultrasound-mediated technology platform for targeted therapeutic enhancement Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-med ...

INTERNATIONAL MEDIA ACQUISITION CORP. 87 M $
Logo International Media Acquisition Corp.

International Media Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It ...

ME THERAPEUTICS HOLDINGS INC. 64 M $
Logo ME Therapeutics Holdings Inc.

ME Therapeutics Holdings Inc. is a Canada-based biotechnology company. The Company is involved in the discovery and development of novel immuno oncology therapeutics targeting immune suppression in cancer. The Company’s lead candidate is a novel high af ...

ACASTI PHARMA INC. 27 M $
Logo Acasti Pharma Inc.

Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH ...

KEYH ACQUPAR 25 M $
Logo KEYH ACQUPAR

Keyarch Acquisition Corporation is a blank check company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more bus ...

SOCL CAPI 241 M $
Logo SOCL CAPI

Social Capital Suvretta Holdings Corp. III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses ...

ENPHYS ACQUISITION CORP. 163 M $
Logo Enphys Acquisition Corp.

Enphys Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It ...

FTAC EMERALD ACQUISITION CORP. 155 M $
Logo FTAC Emerald Acquisition Corp.

FTAC Emerald Acquisition Corp. is a blank check company. The Company is formed for the purpose of entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more busi ...

ICOSAVAX, INC. 778 M $
Logo Icosavax, Inc.

Icosavax, Inc. is a biopharmaceutical company. The Company uses its virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with a focus on life-threatening respiratory diseases. Its VLP platform technology is design ...

IMMUNOME, INC. 732 M $
Logo Immunome, Inc.

Immunome, Inc. is a biotechnology company engaged in developing targeted cancer therapies. The Company's portfolio pursues each target with a modality appropriate to its biology, including immunotherapies, radioligand therapies and Antibody-Drug Conjugate ...

STANLEY LIFESTYLES LIMITED 345 M $
Logo Stanley Lifestyles Limited

Stanley Lifestyles Ltd is an India-based company operating a super-premium and luxury furniture brand. It retails its furniture products under the Stanley brand. Its product portfolio includes sofas, cabinetry and furniture for living rooms, dining rooms, ...

IGM BIOSCIENCES, INC. 401 M $
Logo IGM Biosciences, Inc.

IGM Biosciences, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing and delivering a new class of medicines to treat patients with cancer and autoimmune and inflammatory diseases. The Company’s pipeline of clinical and ...

MARBLEGATE ACQUISITION CORP. 128 M $
Logo Marblegate Acquisition Corp.

Marblegate Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The ...

COLOMBIER ACQUISITION CORP. II 218 M $
Logo Colombier Acquisition Corp. II

Colombier Acquisition Corp. II is a blank check company. The Company is formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has n ...

GOLDENSTONE ACQUISITION LIMITED 77 M $
Logo Goldenstone Acquisition Limited

Goldenstone Acquisition Limited is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more bus ...

FUTURE MEDICINE CO., LTD. 14 M $
Logo Future Medicine Co., Ltd.

Future Medicine Co Ltd is a Korea-based company mainly engaged in the synthetic drug development business. The Company is engaged in the development and sale of anti-inflammatory and anti-fibrotic agents, targeted anticancer drugs, immune anticancer drugs ...

BIRCHTREE INVESTMENTS LTD. 1 M $
Logo Birchtree Investments Ltd.

Birchtree Investments Ltd. is a Canada-based investment company. The Company's business objective is to give its shareholders the opportunity to indirectly participate in investments in the early stages of a target company's development; technologies that ...

PYXIS ONCOLOGY, INC. 188 M $
Logo Pyxis Oncology, Inc.

Pyxis Oncology, Inc. is a clinical-stage company focused on developing therapeutics to target difficult-to-treat cancers. The Company is building therapeutics that hold the potential for mono and combination therapies. Its clinical program portfolio inclu ...

CANTABIO PHARMACEUTICALS, INC. 24 348 $
Logo Cantabio Pharmaceuticals, Inc.

Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company. The Company is focused on commercializing therapies and the intellectual property generated from its research and development activities for Parkinson’s disease (PD), Alzheimerâ ...

CITIUS RESOURCES PLC 2 M $
Logo Citius Resources Plc

Citius Resources Plc is a United Kingdom-based company. The Company is formed to undertake an acquisition of a target company or business. The Company's efforts in identifying a prospective target company or business shall not be limited to a particular i ...


1234Next

No results for this search

  1. Stock Market
  2. Advanced search
  3. 가상계좌관리 ( @MOONPAY_CALL ) 장집 국민은행 제주은행가상 국민은행가상계좌 target=_blank